课题基金 / 基金详情

Characterising the Muscarinic Receptor Deficit in Schizophrenia

Characterising the Muscarinic Receptor Deficit in Schizophrenia
精神分裂症毒蕈碱受体缺陷的特征
批准号:
nhmrc : 2000779
负责人:
金额:
$47.65万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Ideas Grants
财政年份:
2021
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2021-01-01 至 2024-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Post-mortem examination of the brains of schizophrenia patients reveals a substantial loss of muscarinic receptors. This is likely to be clinically very important if it can also be confirmed in living patients. Having developed a new scanning technique that shows muscarinic receptors in the living brain, we will now scan patients with schizophrenia to see if they also show this receptor loss, and see how it affects them. This could open new doors to understanding and treating the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金